Showing results (51-60 of 357) with videos related to
Sort By:
Pageof 36
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.Cancer|June 15, 2007
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicityElias Jabbour, Jorge Cortes, Hagop Kantarjian, et al.Transplantation and Cellular Therapy|August 17, 2025
The Impact of Isolated HLA-DQB1 Mismatch and Donor Age in Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant CyclophosphamideRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.American Journal of Hematology|October 18, 2023
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient ageRima M Saliba, Christopher G Kanakry, Shahinaz Gadalla, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.The Lancet. Haematology|January 15, 2016
Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysisShahrukh Hashmi, Mohammad Ahmed, M Hassan Murad, et al.Journal of Geriatric Oncology|September 8, 2021
Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot studyRachel Ombres, Jude K A des Bordes, Uday R Popat, et al.Cancer|December 18, 2008
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimensDushyant Verma, Susan O'Brien, Deborah Thomas, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 19, 2018
Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplantAllison Mah, George M Viola, Ella Ariza Heredia, et al.Leukemia & Lymphoma|June 28, 2016
Stem cell transplantation outcomes in lymphoblastic lymphomaJonathan E Brammer, Issa Khouri, David Marin, et al.Pageof 36